10
Participants
Start Date
May 3, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
allogeneic γ9δ2 T Cells
dose escalation (3+3) : dose 1 (5 × 10\^7cells/kg) ,dose 2 (1 × 10\^8 cells/kg) ,dose 3 (2 × 10\^8cells/kg)
Fludarabine
Intravenous fludarabine on days-5 and -4,the infusion dose is adjusted according to the subject's condition
Cyclophosphamide
Intravenous cyclophosphamide on days -5、-4、and -3, the infusion dose is adjusted according to the subject's condition
Zoredronic acid
Intravenous zoredronic acid 50ug/kg 24 hours before cell infusion(or according to the dosage of the instruction)(If applicable)
RECRUITING
Anhui Provincial Hospital, Hefei
Anhui Provincial Hospital
OTHER_GOV